Immunotherapy is promising for cancer treatment. The key to improving the therapeutic effect is to drive the patient’s own immune system to produce a strong, effective, and enduring tumor-specific immune response. Engineered nanoplatforms show promising potential in strengthening antitumor immune responses.
Click here for original story, Novel targeted nano-immunostimulant for cancer immunotherapy developed
Source: Phys.org